Global Dog Dewormers Market Size By Type (Topical, Oral), By Application (Heartworms, Hookworms), By Region, And Segment Forecasts, 2023 to 2032

The Global Dog Dewormers Market was valued at USD 2.3 billion in 2023 and is projected to reach USD 3.8 billion by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. Increasing pet adoption rates, heightened awareness of pet healthcare, and routine veterinary practices are significantly boosting demand for dog deworming products. With a growing emphasis on preventive care, regular deworming has become a cornerstone in canine health management, driving steady growth in both prescription and over-the-counter product segments.

Drivers:

1. Rising Pet Ownership Globally:

The increasing number of households owning dogs, especially in urban areas, is fueling the demand for deworming products to maintain pet health and prevent zoonotic infections.

2. Growing Awareness of Zoonotic Diseases:

As public knowledge of parasitic infections that can spread from pets to humans increases, responsible pet owners are more proactive in administering regular deworming treatments.

3. Expansion of Veterinary Services:

Improved access to veterinary clinics, especially in developing nations, is driving greater compliance with deworming schedules, contributing to market expansion.

Restraints:

1. Limited Access in Rural Areas:

Despite the growth in urban regions, rural and underdeveloped areas still face challenges related to access and affordability of veterinary services and pet healthcare products.

2. Side Effects and Resistance Concerns:

Potential side effects and emerging resistance to common anthelmintic drugs may deter some consumers and prompt more cautious product selection, slowing market growth in certain segments.

Opportunity:

1. Development of Broad-Spectrum and Palatable Formulations:

Innovation in multi-parasite treatment and easy-to-administer formats (chewables, flavored tablets) is opening new avenues for manufacturers.

2. Expansion in Emerging Economies:

As pet ownership rises in emerging markets like India, Brazil, and Southeast Asia, demand for affordable and accessible dog dewormers is expected to surge.

Market by System Type Insights:

By system type, Oral Dewormers dominated the market in 2023, accounting for the largest revenue share due to their ease of administration and wide availability. Chewable tablets, in particular, are preferred for their convenience and palatability. Meanwhile, Topical Dewormers are gaining traction, especially in combination products that target multiple parasites (fleas, ticks, and worms), offering added value to pet owners.

Market by End-use Insights:

The Retail Pharmacies and Pet Stores segment emerged as the dominant distribution channel in 2023. Over-the-counter availability of dog dewormers makes it convenient for pet owners to maintain regular dosing schedules. Veterinary Clinics, however, remain critical for initial diagnosis, professional recommendations, and administering higher-strength formulations, particularly in severe infestation cases.

Market by Regional Insights:

North America led the global dog dewormers market in 2023, fueled by high pet adoption rates, well-established veterinary infrastructure, and high consumer spending on pet care. Europe follows closely, with countries like Germany and the UK exhibiting strong demand. Asia-Pacific is forecasted to be the fastest-growing region through 2031, driven by rising pet care awareness, increasing disposable incomes, and rapid urbanization in countries like India and China.

Competitive Scenario:

Leading players in the Global Dog Dewormers Market include Bayer AG (Elanco Animal Health), Boehringer Ingelheim, Zoetis Inc., Merck Animal Health, Virbac, Vetoquinol, PetIQ, and Ceva Santé Animale. These companies focus on strategic mergers, product line extensions, and enhanced distribution networks. Notable developments include:

2023: Zoetis launched a next-gen broad-spectrum chewable dewormer in the U.S. for monthly protection.

2024: Virbac introduced an eco-friendly packaging line for its deworming tablets, targeting sustainable pet care trends.

2025: Elanco expanded its presence in Southeast Asia through strategic partnerships with veterinary chains to improve product accessibility.

Scope of Work – Global Dog Dewormers Market

Key Market Developments:

Zoetis (2023): Introduced a new once-a-month chewable dewormer for broad-spectrum protection.

Virbac (2024): Launched a sustainable packaging initiative for its canine parasite products.

Merck (2025): Expanded its e-commerce presence to improve access to prescription-only dewormers in rural regions of North America.

FAQs:

What is the current market size of the Global Dog Dewormers Market?

The market was valued at USD 2.3 billion in 2023.

What is the major growth driver of the Global Dog Dewormers Market?

The key growth driver is the rising global pet ownership and increased focus on canine health.

Which is the largest region during the forecast period in the Global Dog Dewormers Market?

North America holds the largest share due to high spending on pet healthcare and advanced veterinary services.

Which segment accounted for the largest market share in the Global Dog Dewormers Market?

The Oral Dewormers segment accounted for the largest share in 2023.

Who are the key market players in the Global Dog Dewormers Market?

Key players include Zoetis Inc., Merck Animal Health, Bayer AG (Elanco), Virbac, Boehringer Ingelheim, and Ceva Santé Animale.